Brown, Jacques P

A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy

Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology

Adrenal Hormones and DisordersPharmacovigilance and Adverse Drug Reactions

Cited by 1,268

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine

Bone health and osteoporosis researchBone health and treatments

Cited by 1,258

Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine

Bone health and osteoporosis researchBone health and treatments

Cited by 1,258

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Bone, H. G., Wagman, R. B., Brandi, M. L., Brown, J. P., Chapurlat, R., Cummings, S. R., Czerwiński, E., Fahrleitner-Pammer, A., Kendler, D. L., Lippuner, K., et al. (2017) · The Lancet Diabetes & Endocrinology

Bone health and osteoporosis researchBone health and treatments

Cited by 996

Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.

Laurin, N., Brown, J. P., Morissette, J., & Raymond, V. (2002) · The American Journal of Human Genetics

Bone Metabolism and DiseasesAlkaline Phosphatase Research Studies

Cited by 563

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Langdahl, B. L., Libanati, C., Crittenden, D. B., Bolognese, M. A., Brown, J. P., Daizadeh, N. S., Dokoupilova, E., Engelke, K., Finkelstein, J. S., Genant, H. K., et al. (2017) · The Lancet

Bone health and osteoporosis researchBone health and treatments

Cited by 497

The Atypical PKC-Interacting Protein p62 Is an Important Mediator of RANK-Activated Osteoclastogenesis

Durán, A., Serrano, M., Leitges, M., Flores, J. M., Picard, S., Brown, J. P., Moscat, J., & Diaz-Meco, M. T. (2004) · Developmental Cell

Bone Metabolism and DiseasesNF-κB Signaling Pathways

Cited by 316

Bone turnover markers in the management of postmenopausal osteoporosis

Brown, J. P., Albert, C., Nassar, B. A., Adachi, J. D., Cole, D., Davison, K. S., Dooley, K. C., Don-Wauchope, A., Douville, P., Hanley, D. A., et al. (2009) · Clinical Biochemistry

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 204

The care gap in diagnosis and treatment of women with a fragility fracture

Bessette, L., Ste-Marie, L.-G., Jean, S., Davison, K. S., Beaulieu, M., Baranci, M., Bessant, J., & Brown, J. P. (2008) · Osteoporosis International

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 186